Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
RIMECARD: ucMSC in Heart Failure
NCT01739777Phase 2Completed
- Start
- Dec 2012
- Primary completion
- Jun 2015
- Modality
- Stem Cell Therapies
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of human umbilical cord mesenchymal stem cells in heart failure (HF) and dilated cardiomyopathy (DCM). Primary endpoint: Change in global left ventricular ejection fraction at 12 months. Started Dec 2012; status: completed.
02
Drugs
human umbilical cord mesenchymal stem cells
03
Conditions
heart failure (HF)dilated cardiomyopathy (DCM)
Beyond the preview
Go deeper on NCT01739777.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01739777.